For example, mutations in SPOP, which occur early in the development of prostate cancer, are most appropriately modeled starting with normal luminal stem cells, which provide an appropriate context, as compared with prostate cancer cell lines, which contain several preexisting mutations (43). This evidence concerns the gene SPOP and prostate cancer.